Biologic Drugs With Established Pharmaceutical Class: RANK Ligand Inhibitor
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: RANK Ligand Inhibitor
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | ⤷ Start Trial | ⤷ Start Trial |
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | 6,740,522 | ⤷ Start Trial |
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | 7,097,834 | ⤷ Start Trial |
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | 7,364,736 | ⤷ Start Trial |
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | 7,411,050 | ⤷ Start Trial |
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 2010-06-01 | 7,744,886 | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
